Cornea

hTCEpi

The cornea is constantly exposed to the outside environment and thus subject to damage due to various insults such as infections, drug- or chemical induced toxicity. In order to sustain such damage, the corneal epithelial cells form a resistance barrier, which is continuously renewed by stem cells located in the adjacent limbal region.

Evercyte offers a continuously growing corneal epithelial cell line with functions that resemble that of the corresponding primary counterpart cells. Therefore, our cells qualify for studying drug transport, drug- and chemical-induced toxicity on the corneal epithelium as well as inflammation processes and wound healing.

Print Friendly, PDF & Email

from

€ 1600,–

hTCEpi
Cat#: CHT-045-0237

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

about
our cells

telomerized (hTERT immortalized) cells in biotechnology and biomedicine

study of inflammation

hTCEpi cells are fit for purpose to study inflammation in dry eye disease

Related Products

telomerized human cells from various tissues and body fluids

Related Services

testing cytotoxic effects of novel compounds on corneal epithelial cells

Print Friendly, PDF & Email

from

€ 1300,–

hTCEpi
Cat#: CHT-045-0237

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO